Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model by Robin I. J. Merkx, Mark Rijpkema, Gerben M. Franssen, Annemarie Kip, Bart Smeets, Alfred Morgenstern, Frank Bruchertseifer, Eddie Yan, Michael P. Wheatcroft, Egbert Oosterwijk, Peter F. A. Mulders, Sandra Heskamp

Subjects: Get full text

Quantitative SPECT/CT imaging of actinium-225 for targeted alpha therapy of glioblastomas by Monika Tulik, Radosław Kuliński, Zbisław Tabor, Beata Brzozowska, Piotr Łaba, Frank Bruchertseifer, Alfred Morgenstern, Leszek Królicki, Jolanta Kunikowska

Subjects: Get full text

Development of a multi faceted platform containing a tetrazine, fluorophore and chelator: synthesis, characterization, radiolabeling, and immuno-SPECT imaging by Anthony W. McDonagh, Brooke L. McNeil, Julie Rousseau, Ryan J. Roberts, Helen Merkens, Hua Yang, François Bénard, Caterina F. Ramogida

Subjects: Get full text

Ac-EAZY! Towards GMP-Compliant Module Syntheses of ²²⁵Ac-Labeled Peptides for Clinical Application by Marc Pretze, Falk Kunkel, Roswitha Runge, Robert Freudenberg, Anja Braune, Holger Hartmann, Uwe Schwarz, Claudia Brogsitter, Jörg Kotzerke

Subjects: “…actinium-225…”
Get full text

Development of [225Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration by Ashleigh Hull, William Hsieh, Artem Borysenko, William Tieu, Dylan Bartholomeusz, Eva Bezak

Subjects: “…Actinium-225…”
Get full text

Real-time trajectory imaging of alpha particles emitted from actinium-225 and its daughter radionuclides by Seiichi Yamamoto, Masao Yoshino, Kenji Shirasaki, Kohei Nakanishi, Kei Kamada, Akira Yoshikawa, Jun Kataoka

Subjects: Get full text

A Monte Carlo Method for Determining the Response Relationship between Two Commonly Used Detectors to Indirectly Measure Alpha Particle Radiation Activity by Christopher J. Tichacek, Mikalai M. Budzevich, Thaddeus J. Wadas, David L. Morse, Eduardo G. Moros

Subjects: Get full text

Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand? by Roger M. Pallares, Rebecca J. Abergel, Rebecca J. Abergel

Subjects: Get full text

Dosimetric impact of Ac-227 in accelerator-produced Ac-225 for alpha-emitter radiopharmaceutical therapy of patients with hematological malignancies: a pharmacokinetic modeling ana... by George Sgouros, Bin He, Nitya Ray, Dale L. Ludwig, Eric C. Frey

Subjects: “…Actinium-225…”
Get full text

Recent Innovations and Nano-Delivery of Actinium-225: A Narrative Review by Sipho Mdanda, Lindokuhle M. Ngema, Amanda Mdlophane, Mike M. Sathekge, Jan Rijn Zeevaart

Subjects: “…actinium-225…”
Get full text

Synthesis and Preliminary Biological Evaluations of Fluorescent or 149Promethium Labeled Trastuzumab-Polyethylenimine by Jonathan Fitzsimmons, Tapan Nayak, Cathy Cutler, Robert Atcher

Subjects: Get full text

Two diverse carriers are better than one: A case study in α‐particle therapy for prostate specific membrane antigen‐expressing prostate cancers by Dominick Salerno, Alaina Howe, Omkar Bhatavdekar, Anders Josefsson, Jesus Pacheco‐Torres, Zaver M. Bhujwalla, Kathleen L. Gabrielson, Stavroula Sofou

Subjects: “…Actinium‐225…”
Get full text

Alpha-Emitting Radionuclides: Current Status and Future Perspectives by Matthias Miederer, Martina Benešová-Schäfer, Constantin Mamat, David Kästner, Marc Pretze, Enrico Michler, Claudia Brogsitter, Jörg Kotzerke, Klaus Kopka, David A. Scheinberg, Michael R. McDevitt

Subjects: Get full text

Design of a Thorium Metal Target for ²²⁵Ac Production at TRIUMF by Andrew K.H. Robertson, Andrew Lobbezoo, Louis Moskven, Paul Schaffer, Cornelia Hoehr

Subjects: “…actinium-225…”
Get full text

A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225 by Evangelia-Alexandra Salvanou, Dimitris Stellas, Charalampos Tsoukalas, Barbara Mavroidi, Maria Paravatou-Petsotas, Nikolaos Kalogeropoulos, Stavros Xanthopoulos, Franck Denat, Gautier Laurent, Rana Bazzi, Stephane Roux, Penelope Bouziotis

Subjects: “…actinium-225…”
Get full text

Evaluation of the tolerability and safety of [225Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study by Sui wai Ling, Astrid A. M. van der Veldt, Mark Konijnenberg, Marcel Segbers, Eline Hooijman, Frank Bruchertseifer, Alfred Morgenstern, Erik de Blois, Tessa Brabander

Subjects: Get full text

Development of 225Ac-doped biocompatible nanoparticles for targeted alpha therapy by Miguel Toro-González, Ngozi Akingbesote, Amber Bible, Debjani Pal, Brian Sanders, Alexander S. Ivanov, Santa Jansone-Popova, Ilja Popovs, Paul Benny, Rachel Perry, Sandra Davern

Subjects: “…Actinium-225…”
Get full text

Efficient Production of the PET Radionuclide ¹³³La for Theranostic Purposes in Targeted Alpha Therapy Using the ¹³⁴Ba(p,2n)¹³³La Reaction by Santiago Andrés Brühlmann, Martin Kreller, Hans-Jürgen Pietzsch, Klaus Kopka, Constantin Mamat, Martin Walther, Falco Reissig

Subjects: Get full text

Actinium-225 in Targeted Alpha Therapy by A. K. M. Rezaur Rahman, Mahathe Hasan Babu, Mustofa Khalid Ovi, Md. Mahiuddin Zilani, Israt Sultana Eithu, Amit Chakraborty

Subjects: “…actinium-225…”
Get full text

A GATE simulation study for dosimetry in cancer cell and micrometastasis from the 225Ac decay chain by Helena Koniar, Cassandra Miller, Arman Rahmim, Paul Schaffer, Carlos Uribe

Subjects: “…Actinium-225…”
Get full text